Table 2.
Prevalencea of Meeting the Minimal Aerobic Physical Activity Guideline Among US Adults with Selected Chronic Health Conditions by 3-Year Intervals and Age Group, United States 1998–2018
| Chronic Health Condition, Overall and by Age Group | 3-Year Intervals | Absolute change from first to last time interval | Test for Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 1998–2000 | 2001–2003 | 2004–2006 | 2007–2009 | 2010–2012 | 2013–2015 | 2016–2018 | |||
| % (95% CI) | % (95% CI) | % (95% CI) | % (95% CI) | % (95% CI) | % (95% CI) | % (95% CI) | % (95% CI) | ||
| Diabetes b | |||||||||
| No | 41.8 (41.3, 42.4) | 43.8 (43.2, 44.5) | 42.1 (41.5, 42.8) | 45.0 (44.2, 45.8) | 49.9 (49.2, 50.5) | 51.3 (50.6, 51.9) | 55.1 (54.2, 55.9) | 13.2 (12.2,14.3) | L, Q |
| Yes | 31.6 (29.3, 34.0) | 33.2 (30.8, 35.7) | 35.9 (33.5, 38.3) | 35.4 (32.3, 38.7) | 36.0 (33.4, 38.7) | 36.8 (34.5, 39.2) | 43.5 (40.8, 46.1) | 11.9 (8.3,15.4) | L |
| Age group (y) | |||||||||
| 18–34 | 38.0 (32.3, 44.1) | 40.3 (34.6, 46.3) | 48.2 (41.8, 54.5) | 45.5 (37.5, 53.8) | 44.1 (38.0, 50.3) | 47.0 (40.9, 53.1) | 55.9 (49.2, 62.3) | 17.8 (9.0,26.7) | L |
| 35–64 | 28.4 (26.5, 30.4) | 30.7 (28.7, 32.8) | 30.5 (28.7, 32.3) | 31.0 (28.9, 33.2) | 33.1 (31.4, 34.8) | 32.3 (30.7, 34.0) | 37.7 (35.7, 39.8) | 9.3 (6.5,12.1) | L |
| ≥65 | 21.0 (19.2, 23.0) | 23.8 (21.8, 25.8) | 22.0 (20.2, 23.9) | 24.1 (22.1, 26.1) | 25.5 (23.9, 27.2) | 26.5 (24.9, 28.1) | 29.5 (27.9, 31.2) | 8.5 (6.0,11.0) | L |
| Hypertension | |||||||||
| No | 42.9 (42.3, 43.4) | 44.7 (44.0, 45.3) | 43.2 (42.6, 43.9) | 46.3 (45.4, 47.1) | 51.2 (50.6, 51.9) | 52.6 (51.9, 53.3) | 56.6 (55.7, 57.5) | 13.7 (12.7,14.8) | L, Q |
| Yes | 36.6 (35.5, 37.8) | 38.7 (37.5, 40.0) | 37.4 (36.2, 38.7) | 39.5 (38.2, 40.9) | 43.2 (42.1, 44.3) | 44.8 (43.6, 46.1) | 47.6 (46.1, 49.0) | 11.0 (9.1,12.8) | L, Q |
| Age group (y) | |||||||||
| 18–34 | 44.2 (41.7, 46.8) | 46.0 (43.3, 48.7) | 45.1 (42.2, 48.0) | 47.3 (44.3, 50.3) | 53.4 (50.8, 56.0) | 54.9 (52.1, 57.6) | 55.7 (52.6, 58.8) | 11.5 (7.5,15.5) | L |
| 35–64 | 34.4 (33.2, 35.5) | 36.6 (35.5, 37.8) | 34.9 (33.8, 36.0) | 36.8 (35.5, 38.0) | 39.9 (38.9, 41.0) | 40.6 (39.5, 41.6) | 44.9 (43.6, 46.2) | 10.5 (8.8,12.2) | L, Q |
| ≥65 | 24.7 (23.5, 25.8) | 27.7 (26.5, 28.9) | 26.4 (25.2, 27.6) | 28.3 (27.1, 29.6) | 31.3 (30.1, 32.4) | 32.7 (31.7, 33.8) | 35.7 (34.6, 36.8) | 11.1 (9.5,12.6) | L, Q |
| Coronary Heart Disease | |||||||||
| No | 41.5 (41.0, 42.1) | 43.6 (42.9, 44.2) | 42.0 (41.3, 42.6) | 44.8 (44.0, 45.6) | 49.3 (48.6, 49.9) | 50.5 (49.9, 51.1) | 54.4 (53.5, 55.2) | 12.8 (11.8,13.8) | L, Q |
| Yes | 33.5 (29.7, 37.5) | 35.6 (32.1, 39.2) | 31.5 (27.9, 35.2) | 32.1 (28.0, 36.6) | 36.2 (32.7, 39.8) | 36.2 (32.4, 40.2) | 39.6 (35.6, 43.8) | 6.2 (0.5,11.9) | L |
| Age group (y) | |||||||||
| 18–34 | ~ | ~ | ~ | ~ | ~ | ~ | ~ | ~ | |
| 35–64 | 31.2 (28.9, 33.6) | 31.6 (29.4, 33.9) | 29.3 (27.2, 31.4) | 29.2 (26.5, 32.0) | 32.8 (30.6, 35.2) | 33.1 (30.6, 35.6) | 38.1 (35.3, 40.9) | 6.9 (3.2,10.6) | L, Q |
| ≥65 | 24.1 (22.3, 25.9) | 26.4 (24.8, 28.1) | 23.9 (22.2, 25.6) | 24.6 (22.6, 26.6) | 29.0 (27.1, 31.0) | 29.4 (27.7, 31.2) | 30.6 (28.8, 32.5) | 6.6 (4.0,9.2) | L |
| Stroke | |||||||||
| No | 41.5 (40.9, 42.0) | 43.5 (42.9, 44.1) | 41.8 (41.1, 42.4) | 44.4 (43.6, 45.2) | 49.1 (48.5, 49.7) | 50.3 (49.7, 50.9) | 54.1 (53.3, 55.0) | 12.6 (11.6,13.7) | L, Q |
| Yes | 27.5 (20.8, 35.3) | 30.5 (25.7, 35.6) | 27.4 (22.7, 32.8) | 40.7 (35.9, 45.6) | 29.1 (24.4, 34.4) | 33.6 (28.5, 39.1) | 41.1 (36.4, 45.9) | 13.6 (4.9,22.3) | L |
| Age group (y) | |||||||||
| 18–34 | ~ | ~ | ~ | ~ | ~ | ~ | ~ | ~ | |
| 35–64 | 21.5 (18.1, 25.3) | 26.6 (23.0, 30.6) | 23.7 (20.2, 27.6) | 25.2 (21.8, 28.9) | 26.1 (23.1, 29.4) | 29.0 (25.5, 32.8) | 33.0 (29.3, 36.9) | 11.6 (6.3,16.8) | L |
| ≥65 | 16.6 (14.5, 18.9) | 18.0 (15.8, 20.5) | 16.5 (14.3, 18.9) | 20.9 (18.4, 23.7) | 19.6 (17.1, 22.3) | 20.7 (18.5, 23.1) | 24.0 (21.7, 26.3) | 7.3 (4.2,10.5) | L |
| Cancer | |||||||||
| No | 41.1 (40.6, 41.7) | 43.1 (42.5, 43.7) | 41.3 (40.6, 41.9) | 44.0 (43.2, 44.8) | 48.5 (47.9, 49.2) | 49.9 (49.3, 50.5) | 53.6 (52.7, 54.4) | 12.4 (11.4,13.5) | L, Q |
| Yes | 40.3 (37.8, 42.7) | 43.4 (41.1, 45.7) | 42.2 (39.5, 44.9) | 43.7 (40.7, 46.7) | 50.0 (47.1, 52.8) | 45.0 (42.2, 47.8) | 53.1 (49.9, 56.3) | 12.9 (8.9,16.9) | L |
| Age group (y) | |||||||||
| 18–34 | 42.3 (36.5, 48.4) | 51.7 (46.0, 57.3) | 47.1 (40.4, 53.8) | 47.7 (40.2, 55.3) | 61.5 (54.5, 68.1) | 49.7 (42.3, 57.1) | 62.5 (55.2, 69.2) | 20.1 (10.9,29.3) | L |
| 35–64 | 40.8 (38.7, 42.9) | 42.6 (40.3, 44.9) | 41.7 (39.4, 44.0) | 44.7 (42.1, 47.4) | 46.4 (44.4, 48.5) | 47.3 (45.0, 49.6) | 53.2 (50.9, 55.4) | 12.3 (9.2,15.4) | L, Q |
| ≥65 | 29.5 (27.8, 31.2) | 29.9 (28.1, 31.7) | 31.0 (29.0, 33.1) | 31.6 (29.6, 33.6) | 36.5 (34.9, 38.3) | 36.1 (34.3, 37.8) | 40.2 (38.6, 41.9) | 10.7 (8.3,13.2) | L, Q |
| Arthritis | |||||||||
| No | - | 44.2 (43.6, 44.9) | 42.3 (41.6, 42.9) | 45.7 (44.8, 46.5) | 50.4 (49.8, 51.1) | 51.8 (51.1, 52.5) | 55.4 (54.5, 56.3) | 11.2 (10.1,12.3) | L, Q |
| Yes | - | 40.8 (39.5, 42.2) | 40.1 (38.7, 41.6) | 40.1 (38.3, 42.0) | 43.0 (41.5, 44.6) | 43.5 (41.9, 45.2) | 48.9 (47.0, 50.8) | 8.1 (5.7,10.4) | L, Q |
| Age group (y) | |||||||||
| 18–34 | - | 50.6 (47.4, 53.8) | 51.2 (47.7, 54.7) | 48.4 (44.2, 52.5) | 51.5 (47.9, 55.2) | 51.2 (47.2, 55.3) | 58.2 (54.1, 62.2) | 7.6 (2.4,12.8) | L, Q |
| 35–64 | - | 37.8 (36.6, 39.1) | 36.6 (35.5, 37.8) | 37.5 (36.0, 39.0) | 39.8 (38.6, 41.1) | 40.1 (38.9, 41.4) | 45.4 (44.0, 46.8) | 7.6 (5.7,9.4) | L, Q |
| ≥65 | - | 27.2 (25.9, 28.5) | 27.0 (25.7, 28.3) | 27.0 (25.7, 28.4) | 30.8 (29.5, 32.0) | 32.1 (30.8, 33.4) | 35.7 (34.4, 36.9) | 8.5 (6.7,10.3) | L, Q |
Abbreviations: CI, confidence interval; L, significant linear trend (P < .05); Q, significant quadratic trend (P < .05).
Data source: National Health Interview Survey.
a
Overall estimates are age-standardized to the 2000 US adult population; age-specific estimates are not.
b
Responses from persons who said they had “borderline” diabetes were treated as unknown with respect to diabetes.
~
Estimates suppressed because of sample size <250.